
The Food and Drug Administration is temporarily loosening rules around compounded nutrition products for premature and critically ill newborns after two facilities that supply the specialized IV formula announced they are permanently shutting down.

The Food and Drug Administration is temporarily loosening rules around compounded nutrition products for premature and critically ill newborns after two facilities that supply the specialized IV formula announced they are permanently shutting down.